Anouck Huijbers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anouck Huijbers has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- André M. Deelder
Biomolecular Mass Spectrometry Unit, Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands
1 shared publication - Bart J. A. Mertens
Medical Statistics, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands
1 shared publication - Berit Velstra
Department of Surgery, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333 ZA, Leiden, The Netherlands
1 shared publication - Rob A. E. M. Tollenaar
Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands
1 shared publication - Tim Johannes Adrianus Dekker
Leiden University Medical Center, Leiden, The Netherlands
1 shared publication - Wilma. E. Mesker
Leiden University Medical Center
1 shared publication
Latest Publications
- Open Access
- 26 October 2010
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 11 (11) , 4175-4193
Proteomic Serum Biomarkers and Their Potential Application in Cancer Screening Programs
Early diagnosis of cancer is of pivotal importance to reduce disease-related mortality. There is great need for non-invasive screening methods, yet current screening protocols have limited sensitivity and specificity. The use of serum biomarkers to discriminate cancer patients from healthy persons might be a tool to improve screening programs. Mass spectrometry based proteomics is widely applied as a technology for mapping and identifying peptides and proteins in body fluids. One commonly used approach in proteomics is peptide and protein profiling. Here, we present an overview of profiling methods that have the potential for implementation in a clinical setting and in national screening programs.
- 26 October 2010
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 11 (11) , 4175-4193
Open AccessProteomic Serum Biomarkers and Their Potential Application in Cancer Screening Programs
Early diagnosis of cancer is of pivotal importance to reduce disease-related mortality. There is great need for non-invasive screening methods, yet current screening protocols have limited sensitivity and specificity. The use of serum biomarkers to discriminate cancer patients from healthy persons might be a tool to improve screening programs. Mass spectrometry based proteomics is widely applied as a technology for mapping and identifying peptides and proteins in body fluids. One commonly used approach in proteomics is peptide and protein profiling. Here, we present an overview of profiling methods that have the potential for implementation in a clinical setting and in national screening programs.